Regulators mull restricting Astrazeneca jab for under-40s over blood clot fears

© Provided by City AM

UK scientists are reportedly considering whether under-40s should be advised to have an alternative vaccine to the Astrazeneca jab due to blood clot fears.

Earlier this month it was recommended that under-30s should be offered a different jab as the risk of developing a blood clot outweighed the benefits of receiving the vaccine.

Read more: EU kicks off legal case against Astrazeneca over vaccine supply issues

The risk of developing a serious blood clot has risen from one in 250,000 to around one in 126,600 over the last two weeks, according to data from te Medical Healthcare products and Regulatory Agency, The Telegraph said.

This has prompted the Joint Committee on Vaccination and Immunisation (JCVI) to consider a change of policy.

Video: Janssen vaccine has 'possible link' to blood clots, says European regulator (PA Media)

Janssen vaccine has 'possible link' to blood clots, says European regulator

PA Media See more videos

SHARE

SHARE

TWEET

SHARE

EMAIL

What to watch next

• 

  NASA reveals side-by-side videos from Ingenuity's first flight

  
  Daily Mail
• 

  Never-before-seen video shows DMX performing in Manhattan prison

  
  Daily Mail

Click to expand

Replay Video

• NASA reveals side-by-side videos from Ingenuity's first flight These enhanced side-by-side videos from NASA Persevere's Mastcam-Z reveal plumes from #MarsHelicopter upon takeoff and landing. It helps us better understand the Martian wind, and how dust travels through the Red Planet's atmosphere. Daily Mail
• Never-before-seen video shows DMX performing in Manhattan prison Never-before-seen video shows the late rapper DMX performing for inmates inside a Manhattan prison. Daily Mail

UP NEXT

Read more: Blood clot risk from Covid infection 'eight times higher' than from Astrazeneca vaccine

However, a University of Oxford report published this month showed that the risk of developing a blood clot from catching coronavirus is eight times higher than after being given the Astrazeneca vaccine.

Scientists found that cerebral venous thrombosis (CVT) occurred in 39 per million coronavirus patients, compared with around 5 per million people given the Astrazeneca jab.

Read more: EU regulator probes possible blood clot risk with Johnson & Johnson Covid vaccine

In the study of more than 500,000 patients in the US, the risk of developing a blood clot was reported to be around 100 times higher after contracting coronavirus than normal.

Researchers said the figures should help regulators and the public to better understand the "risk-benefit question" associated with Covid vaccines.

More than half of people in the UK have received their first dose of a Covid vaccine, with the government confident it will meet its deadline to vaccinate all over-18s by the end of July despite supply hiccups with the Astrazeneca jab.

The post Regulators mull restricting Astrazeneca jab for under-40s over blood clot fears appeared first on CityAM.